Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2014 2
2015 2
2016 5
2017 4
2018 4
2019 4
2020 4
2021 6
2022 4
2023 9
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Free PMC article. Clinical Trial.
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST).
Winter-van Rossum I, Weiser M, Galderisi S, Leucht S, Bitter I, Glenthøj B, Hasan A, Luykx J, Kupchik M, Psota G, Rocca P, Stefanis N, Teitelbaum A, Bar Haim M, Leucht C, Kemmler G, Schurr T; EULAST Study Group; Davidson M, Kahn RS, Fleischhacker WW. Winter-van Rossum I, et al. Lancet Psychiatry. 2023 Mar;10(3):197-208. doi: 10.1016/S2215-0366(23)00005-6. Epub 2023 Jan 27. Lancet Psychiatry. 2023. PMID: 36716759 Clinical Trial.
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: nilforooshan r. Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x. Trials. 2019. PMID: 30944040 Free PMC article. Clinical Trial.
P-tau217 and other blood biomarkers of dementia: variation with time of day.
Della Monica C, Revell V, Atzori G, Laban R, Skene SS, Heslegrave A, Hassanin H, Nilforooshan R, Zetterberg H, Dijk DJ. Della Monica C, et al. Among authors: nilforooshan r. Transl Psychiatry. 2024 Sep 13;14(1):373. doi: 10.1038/s41398-024-03084-7. Transl Psychiatry. 2024. PMID: 39271655 Free PMC article.
WhatsApp Doc?
Gould G, Nilforooshan R. Gould G, et al. Among authors: nilforooshan r. BMJ Innov. 2016 Jul;2(3):109-110. doi: 10.1136/bmjinnov-2016-000116. Epub 2016 Apr 12. BMJ Innov. 2016. PMID: 27547446 Free PMC article. No abstract available.
Perspectives and challenges in patient stratification in Alzheimer's disease.
Abdelnour C, Agosta F, Bozzali M, Fougère B, Iwata A, Nilforooshan R, Takada LT, Viñuela F, Traber M. Abdelnour C, et al. Among authors: nilforooshan r. Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y. Alzheimers Res Ther. 2022. PMID: 35964143 Free PMC article. Review.
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N. Banerjee S, et al. Among authors: nilforooshan r. Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105. Health Technol Assess. 2023. PMID: 37929672 Free PMC article. Clinical Trial.
Pupil-linked arousal, cortical activity, and cognition in Alzheimer's disease.
David MCB, Mallas EJ, Li LM, Kolanko MA, Nilforooshan R, Tsoi ML, Karakoc H, Hoang K, Brandt J, Triantafyllou C, Gruia DC, Custovic D, Lally PJ, Zimmerman KA; Care Research and Technology Group of the UK Dementia Research Institute; Malhotra PA, Scott G, Sharp DJ. David MCB, et al. Among authors: nilforooshan r. Brain Commun. 2025 Jul 22;7(4):fcaf236. doi: 10.1093/braincomms/fcaf236. eCollection 2025. Brain Commun. 2025. PMID: 40697964 Free PMC article.
57 results